These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 28211264)
1. Genetics, diagnosis and clinical features of congenital hypodysfibrinogenemia: a systematic literature review and report of a novel mutation. Casini A; Brungs T; Lavenu-Bombled C; Vilar R; Neerman-Arbez M; de Moerloose P J Thromb Haemost; 2017 May; 15(5):876-888. PubMed ID: 28211264 [TBL] [Abstract][Full Text] [Related]
2. Genetic and clinical characterization of congenital fibrinogen disorders in Polish patients: Identification of three novel fibrinogen gamma chain mutations. Wypasek E; Klukowska A; Zdziarska J; Zawilska K; Treliński J; Iwaniec T; Mital A; Pietrys D; Sydor W; Neerman-Arbez M; Undas A Thromb Res; 2019 Oct; 182():133-140. PubMed ID: 31479941 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis of congenital fibrinogen disorders. Lebreton A; Casini A Ann Biol Clin (Paris); 2016 Aug; 74(4):405-12. PubMed ID: 27492693 [TBL] [Abstract][Full Text] [Related]
4. Hypodysfibrinogenemia: A novel abnormal fibrinogen associated with bleeding and thrombotic complications. Amri Y; Kallel C; Becheur M; Dabboubi R; Elloumi M; Belaaj H; Kammoun S; Messaoud T; de Moerloose P; Toumi Nel H Clin Chim Acta; 2016 Sep; 460():55-62. PubMed ID: 27343352 [TBL] [Abstract][Full Text] [Related]
5. Clinical and molecular characterisation of 21 patients affected by quantitative fibrinogen deficiency. Asselta R; Platè M; Robusto M; Borhany M; Guella I; Soldà G; Afrasiabi A; Menegatti M; Shamsi T; Peyvandi F; Duga S Thromb Haemost; 2015 Mar; 113(3):567-76. PubMed ID: 25427968 [TBL] [Abstract][Full Text] [Related]
6. Congenital fibrinogen disorder with a compound heterozygote possessing two novel FGB mutations, one qualitative and the other quantitative. Yoda M; Kaido T; Taira C; Higuchi Y; Arai S; Okumura N Thromb Res; 2020 Dec; 196():152-158. PubMed ID: 32871307 [TBL] [Abstract][Full Text] [Related]
7. Structural and Functional Characterization of Four Novel Fibrinogen Mutations in Ceznerová E; Kaufmanová J; Sovová Ž; Štikarová J; Loužil J; Kotlín R; Suttnar J Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054908 [TBL] [Abstract][Full Text] [Related]
8. Molecular and clinical profile of congenital fibrinogen disorders in Iran, identification of two novel mutations. Tavasoli B; Safa M; Dorgalaleh A; Ghasemi JB; Rezaei Makhouri F; Rezvani MR; Ahmadi A; Tabibian S; Jazebi M; Baghaipour MR; Zaker F Int J Lab Hematol; 2020 Oct; 42(5):619-627. PubMed ID: 32639687 [TBL] [Abstract][Full Text] [Related]
9. Congenital (hypo-)dysfibrinogenemia and bleeding: A systematic literature review. Li Y; Ding B; Wang X; Ding Q Thromb Res; 2022 Sep; 217():36-47. PubMed ID: 35853369 [TBL] [Abstract][Full Text] [Related]
10. Congenital fibrinogen disorders: an update. de Moerloose P; Casini A; Neerman-Arbez M Semin Thromb Hemost; 2013 Sep; 39(6):585-95. PubMed ID: 23852822 [TBL] [Abstract][Full Text] [Related]
11. Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module. Asselta R; Robusto M; Braidotti P; Peyvandi F; Nastasio S; D'Antiga L; Perisic VN; Maggiore G; Caccia S; Duga S J Thromb Haemost; 2015 Aug; 13(8):1459-67. PubMed ID: 26039544 [TBL] [Abstract][Full Text] [Related]
12. Heterozygous variant fibrinogen γA289V (Kanazawa III) was confirmed as hypodysfibrinogenemia by plasma and recombinant fibrinogens. Kaido T; Yoda M; Kamijo T; Taira C; Higuchi Y; Okumura N Int J Lab Hematol; 2020 Apr; 42(2):190-197. PubMed ID: 31957968 [TBL] [Abstract][Full Text] [Related]
13. Congenital afibrinogenemia: Identification and characterization of two novel homozygous fibrinogen Aα and Bβ chain mutations in two Tunisian families. Amri Y; Toumi Nel H; Hadj Fredj S; de Moerloose P Thromb Res; 2016 Jul; 143():11-6. PubMed ID: 27164460 [TBL] [Abstract][Full Text] [Related]
14. Novel variant fibrinogen γp.C352R produced hypodysfibrinogenemia leading to a bleeding episode and failure of infertility treatment. Yoda M; Kaido T; Kamijo T; Taira C; Higuchi Y; Arai S; Okumura N Int J Hematol; 2021 Sep; 114(3):325-333. PubMed ID: 34117991 [TBL] [Abstract][Full Text] [Related]
15. A rare heterozygous variant in FGB (Fibrinogen Merivale) causing hypofibrinogenemia in a Swedish family. Fager Ferrari M; Leinoe E; Rossing M; Norström E; Zetterberg E Blood Coagul Fibrinolysis; 2020 Oct; 31(7):481-484. PubMed ID: 32852326 [TBL] [Abstract][Full Text] [Related]
16. Laboratory and Genetic Investigation of Mutations Accounting for Congenital Fibrinogen Disorders. Neerman-Arbez M; de Moerloose P; Casini A Semin Thromb Hemost; 2016 Jun; 42(4):356-65. PubMed ID: 27019463 [TBL] [Abstract][Full Text] [Related]
17. Risk of bleeding and thrombosis in inherited qualitative fibrinogen disorders. Castaman G; Giacomelli SH; Biasoli C; Contino L; Radossi P Eur J Haematol; 2019 Oct; 103(4):379-384. PubMed ID: 31314131 [TBL] [Abstract][Full Text] [Related]
18. Clinical and biological features of 3 cases of hypofibrinogenemia associated with three different mutations (gamma Ala341Thr, Bbeta Tyr326Cys and Aalpha Asp496Asn). Hanss M; Chevreaud C; French P; Négrier C; de Mazancourt P Thromb Haemost; 2007 Sep; 98(3):689-91. PubMed ID: 17849064 [No Abstract] [Full Text] [Related]
19. Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management. Casini A; Neerman-Arbez M; Ariëns RA; de Moerloose P J Thromb Haemost; 2015 Jun; 13(6):909-19. PubMed ID: 25816717 [TBL] [Abstract][Full Text] [Related]
20. Three cases of congenital dysfibrinogenemia in unrelated Chinese families: heterozygous missense mutation in fibrinogen alpha chain Argl6His. Luo M; Deng D; Xiang L; Cheng P; Liao L; Deng X; Yan J; Lin F Medicine (Baltimore); 2016 Sep; 95(39):e4864. PubMed ID: 27684817 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]